ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Sharon Choi discussing comprehensive genomic profiling of Black and non-Hispanic White men with prostate cancer. Racial ...

ORION CORPORATION PRESS RELEASE 3 JUNE 2025 at 23.30 EEST           U.S. FDA approves third indication of darolutamide for patients with ...

The score ranges from 6 to 10 because grades 1 and 2 are rarely used for cancer diagnosis. (a score of 1-2 means that you do ...

Kicking off the summit, participants immersed themselves in a hands‑on workshop on three‑dimensional (3D) brachytherapy planning. Under the guidance of experienced medical physicists, radiation ...

Shares of ORIC Pharmaceuticals ORIC surged more than 20% in the pre-market hours today after announcing potentially ...

Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to ...

Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...

Inc. reaches a milestone in prostate cancer diagnostics with its clinically validated SUREcore® biopsy needle and coreCARE® ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological ...